Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype

NCT04167345 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped at Sponsor's discretion

Conditions

Alpha 1-Antitrypsin Deficiency

Interventions

DRUG: VX-814
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated